Astatine-211: Its Possible Applications in Cancer Therapy
Overview
Authors
Affiliations
The cyclotron-produced radiohalogen, 211At, is eminently suitable as a possible therapeutic radionuclide. It decays by the emission of 6.8 MeV mean energy alpha-particles, which from a radiobiological viewpoint are of near optimal therapeutic LET. This paper reviews developments in the possible application of [211At]astato-labelled molecules as potential anti-tumour agents. Additionally, radio-dosimetric evidence is presented, and its implications for human cancer therapy are discussed.
Omata A, Kataoka J, Fujieda K, Sato S, Kuriyama E, Kato H Sci Rep. 2020; 10(1):14064.
PMID: 32820211 PMC: 7441182. DOI: 10.1038/s41598-020-71019-5.
Towards elucidating the radiochemistry of astatine - Behavior in chloroform.
Aneheim E, Palm S, Jensen H, Ekberg C, Albertsson P, Lindegren S Sci Rep. 2019; 9(1):15900.
PMID: 31685874 PMC: 6828679. DOI: 10.1038/s41598-019-52365-5.
Langen B, Rudqvist N, Spetz J, Helou K, Forssell-Aronsson E PLoS One. 2018; 13(7):e0197911.
PMID: 30001320 PMC: 6042689. DOI: 10.1371/journal.pone.0197911.
Langen B, Rudqvist N, Spetz J, Swanpalmer J, Helou K, Forssell-Aronsson E Sci Rep. 2016; 6:30738.
PMID: 27779251 PMC: 5078841. DOI: 10.1038/srep30738.
Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure.
Rudqvist N, Spetz J, Schuler E, Langen B, Parris T, Helou K EJNMMI Res. 2015; 5(1):59.
PMID: 26492889 PMC: 4615992. DOI: 10.1186/s13550-015-0137-8.